Aprea Therapeutics Inc.
APRE | NASDAQ
$0.74
-$0.02 (-2.62%)
At close: Sep 21, 2026, 4:00 PM ET
$0.77
+$0.03 (+4.05%)
Pre-market:
Sep 22, 2026, 4:00 AM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -3.59M | -3.29M | -2.46M | -2.97M | -3.24M | -3.93M | -2.89M | -3.78M | -3.47M | -2.81M | -3.44M | -3.2M | -3.26M | -4.38M | -2.44M | -4.02M | -98.26M | -7.94M | -7.76M | -9.45M | -10.25M | -9.67M |
Depreciation & Amortization | 5.75K | 5.43K | 5.43K | 5.43K | 5.43K | 5.43K | 5.43K | 5.43K | 5.3K | 6.16K | 4.99K | 1.43K | 224 | 410 | -2.39K | 61.37K | 63.69K | 63.77K | 65.99K | 69.44K | 60.24K | 76K |
Stock-Based Compensation | 103.19K | 101.07K | 109.02K | 113.75K | 136.73K | 118.63K | 126.03K | 149.09K | 128.49K | 85.83K | 82.86K | 76.03K | 269.32K | 16.24K | 57.36K | 38.24K | 14.8M | 2.08M | 2.09M | 2.04M | 1.86M | 1.82M |
Other Working Capital | 16.76K | 399.88K | -736.79K | 230.33K | 26.51K | 197.57K | -910.13K | 937.95K | 42.35K | -811.36K | -1.27M | 1.15M | -477.32K | 1.39M | -1.37M | 210.51K | 48.27K | 214.77K | -3.74M | -1.1M | 1.42M | -2.18M |
Other Non-Cash Items | -2.95K | -7.71K | 47.75K | 5.69K | 29.12K | 51.8K | -39.19K | 35.49K | 5.5K | -56.18K | 78.61K | 2.88K | -56.36K | 13.8K | 33.6K | -24.35K | 72.37M | -136.21K | -70.17K | 21.91K | 252.84K | -521.98K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 206.56K | 432.41K | -667.87K | -323.69K | -63.17K | 125.63K | -708.38K | 1.13M | -310.86K | -1.16M | -462.86K | 882.21K | -170.99K | 1.37M | -1.67M | -2.64M | 2.12M | 429.75K | -4.51M | -908.99K | 322.55K | -3.23M |
Operating Cash Flow | -3.28M | -2.76M | -2.96M | -3.17M | -3.13M | -3.63M | -3.51M | -2.47M | -3.64M | -3.94M | -3.74M | -2.24M | -3.22M | -2.98M | -4.02M | -6.59M | -8.9M | -5.5M | -10.18M | -8.23M | -7.75M | -11.52M |
Capital Expenditures | -15.4K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -7.5K | -7.98K | -7.15K | -85.94K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -348 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -15.75K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -7.5K | -7.98K | -7.15K | -85.94K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -2.44M | -474.66K | -371.64K | -17.44K | -14.91K | -3.39K | -6.35K | -1.16K | -21.06K | -1.29M | n/a | n/a | n/a | -648.93K | n/a | n/a | n/a | n/a | 1.66M | 86.97K | n/a | n/a |
Financial Cash Flow | -1.94M | 34.62M | 3.84M | 357.94K | 384.88K | 55.85K | 134.41K | -1.16K | -21.06K | 14.71M | n/a | n/a | n/a | 5.14M | 98.53K | 584.45K | n/a | n/a | 1.66M | 86.97K | n/a | n/a |
Net Cash Flow | -5.23M | 31.87M | 881.55K | -2.81M | -2.74M | -3.57M | -3.4M | -2.44M | -3.68M | 10.76M | -3.75M | -2.33M | -3.27M | 2.21M | -4.33M | -5.95M | -8.59M | -5.42M | -8.35M | -8.38M | -7.81M | -11.4M |
Free Cash Flow | -3.29M | -2.76M | -2.96M | -3.17M | -3.13M | -3.63M | -3.51M | -2.47M | -3.65M | -3.94M | -3.75M | -2.33M | -3.22M | -2.98M | -4.02M | -6.59M | -8.9M | -5.5M | -10.18M | -8.23M | -7.75M | -11.52M |
Adj. Free Cash Flow | -3.4M | -2.86M | -3.07M | -3.28M | -3.27M | -3.75M | -3.64M | -2.62M | -3.78M | -4.03M | -3.83M | -2.4M | -3.49M | -3M | -4.08M | -6.63M | -23.7M | -7.58M | -12.27M | -10.27M | -9.62M | -13.34M |
Maintenance CapEx | -5.75K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Growth CapEx | -9.65K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -7.5K | -7.98K | -7.15K | -85.94K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Owner Earnings | -3.28M | -2.76M | -2.96M | -3.17M | -3.13M | -3.63M | -3.51M | -2.47M | -3.64M | -3.94M | -3.74M | -2.24M | -3.22M | -2.98M | -4.02M | -6.59M | -8.9M | -5.5M | -10.18M | -8.23M | -7.75M | -11.52M |
Add to Watchlist
Select watchlists to add or remove APRE